This site provides INTERCEPT product information for Health Care Professionals in the United States.

Cerus Webinars

Review of Neonate to Pediatric Patient Outcomes Transfused with Amotosalen/UVA Treated Platelets

Runtime: 21 minutes

Leading US hospitals1 are implementing PR platelets to ensure platelet availability and safety across a broad spectrum of pathogens. Doctor Dawn Ward of UCLA shares study findings that assess PR platelet hemostatic efficacy via platelet utilization, as well as PR platelet safety through the evaluation of transfusion reactions in pediatric and neonatal patients.
Presented by:

Dawn C. Ward, MD
Associate Clinical Professor
David Geffen School of Medicine 
Department of Pathology and Laboratory Medicine
Associate Medical Director, Transfusion Medicine
UCLA Health

References: U.S. News & World Report Hospital Rankings & Ratings, 2020-2021,

Watch the Replay
runtime: 21 min